From April 20 to 22, the Euskalduna Congress Palace of Bilbao will host the XXVII edition of the National Congress of the Spanish Diabetes Society (SED).A meeting point for the multidisciplinary team that serves people with diabetes throughout their lives: endocrinologists, educators, family doctors, pediatricians, cardiologists, podians, gynecologists, ophthalmologists, ... but also for those researchers, clinical and basic,that work in search of advances in the knowledge of the disease.
The National Congress of the Spanish Diabetes Society is inaugurated on the 20th in the afternoon with a joint session with the Spanish Diabetes Federation (Fede), where the accent will be emphasized in aspects of special interest and novelty for patients.Subsequently to this act, the thirst and its foundation organize a popular march/race against diabetes, which will travel some main areas of the city and that is open to the entire population.
During the National Congress of the Spanish Diabetes Society, which will congregate about 1,300 professionals, issues of special socio -health importance will be addressed, with the presentation of important novelties.The linkage and future repercussions of gestational diabetes, cardiovascular safety in people with diabetes, the relationship between diabetes and neurodegeneration, new trends in food and exercise, bone fragility associated with diabetes or the influence of factors or the influence of factorsenvironmental in the development of this metabolic disease.
In the National Congress of the Spanish Society of Diabetes, good clinical practices will also be presented with new models of attention, the novel approach to diabetic retinopathy and about the management of diabetes related to cystic fibrosis will be discussed.Monographic meetings with experts will serve, on the other hand, to deepen issues such as diabetes in adolescence, biosimilar contributions, barriers for a good treatment of diabetes in immigrant population or oral pathology in diabetes.
They also highlight some master conferences.Dr. Robert E. Ratner (Virginia, USA) will highlight some alarming data on the growing prevalence and associated cost of diabetes and prediabetes, underlining the possibility of interfering in the natural history of the disease;For his part, Dr. Andrew Hattersley (Devon, United Kingdom) will provide novel data on monogenic diabetes;and Dr. Miriam Cnop (Brussels, Belgium) will decipher some molecular mechanisms involved in the failure of beta cells in type 2 diabetes.
Official program at Link
